TQC3564

N/A

Report date: 2025/09/05 20:01:20
NME

Base Information

Drug NameTQC3564
Drug Alias NameTQC-3564TQC3564
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionProstaglandin D2 receptor 2 antagonists
TargetsProstaglandin D2 receptor 2
Therapy Area/IndicationsRhinitis, AllergicAsthmaRhinitis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaDiscontinued
Originator CompaniesJiangsu Chia Tai-Tianqing Pharmaceutical Co LtdLianyungang Runzhong Pharmaceutical Co Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesN/A
Inactive CompaniesJiangsu Chia Tai-Tianqing Pharmaceutical Co Ltd
Active IndicationsN/A
Inactive IndicationsRhinitis, AllergicAsthmaRhinitis

Other Information

ATC CodeN/A
Related LinksN/A